LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-18,88 % | 10,91 Mrd. | |
+53,75 % | 3,3 Mrd. | |
-32,50 % | 2,19 Mrd. | |
-14,31 % | 2,16 Mrd. | |
-26,83 % | 1,5 Mrd. | |
+28,55 % | 1,09 Mrd. | |
-3,28 % | 737 Mio. | |
-23,50 % | 404 Mio. | |
-43,27 % | 386 Mio. |